Company: QTIWW
Filing Date: 2025-11-03
Form Type: S-1
Source: 0001628280-25-048373
Chunk: 256

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-11-03
Form: S-1
Chunk 256
---
5 and remaining two-thirds vesting quarterly over two years thereafter. The stock options have an exercise price of $2.25 per option and a grant date fair value of $1.41 per option.

<div align='center'>166</div>

### EXECUTIVE AND DIRECTOR COMPENSATION

#### Executive Officer Compensation
QT Imaging’s named executive officers for the year ended December 31, 2024, which consisted of QT Imaging’s chief executive officer and chief financial officer, were:

• Dr. Raluca Dinu, QT Imaging’s President and Chief Executive Officer; and,

• Anastas Budagov, QT Imaging’s Chief Financial Officer.

#### 2023 and 2024 Summary Compensation Table
The following table sets forth information regarding the compensation of QT Imaging’s named executive officers for the years ended December 31, 2023 and 2024.

| Name and Principal Position                                          
 Dr. Raluca Dinu(2)                                                   
 President and Chief Executive Officer                                |     | Year 
 2023 |     |   |         |     | Salary 
 ($)    |       — |     |   |         |     | Option Awards ($)(1) | — |     |   |        |     | Bonus 
 ($)   | — |     |   |     | All Other    
 Compensation 
 ($)          |      — |     |   |         |     | Total 
 ($)   |       — |
|:---------------------------------------------------------------------|:----|-----:|:----|:--|--------:|:----|:-------|--------:|:----|:--|--------:|:----|:---------------------|:--|:----|:--|-------:|:----|:------|:--|:----|:--|:----|:-------------|-------:|:----|:--|--------:|:----|:------|--------:|
| 2024                                                                 |     |      |     | $ | 359,731 |     |        |         |     | $ | 279,070 |     |                      |   |     |   |      — |     |       |   |     | — |     |              |        |     | $ | 638,801 |     |       |         |
| John Klock, M.D.                                                     
 Former President and Chief Executive Officer & Chief Medical Officer |     | 2023 |     |   |         |     |        |       — |     |